Filing Flows

Filing Flows › NRX Pharmaceuticals (NRXP) › Next earnings date

NRX Pharmaceuticals (NRXP) earnings on Nov 12, 2026: what to expect

NRX Pharmaceuticals (NRXP) is expected to report earnings on Nov 12, 2026 (estimated), in 4 days, for the quarter ending Sep 30, 2026. Analysts expect EPS of −$0.15 (1 estimate) on revenue of $1.3M, against −$0.51 and $242K a year ago. It beat the EPS estimate in 50% of the quarters on record; Filing Flows' model gives it a 65% chance of beating next time.

Report dateNov 12, 2026 (estimated)
Days to go4
EPS estimate−$0.15
Revenue estimate$1.3M
Beat rate50%

The last report

NRX Pharmaceuticals reported revenue of $1.1M for the second quarter 2026, net loss $16.5M: Therapy $871K, Procedures $230K. How it makes money → · Every quarter →

NRX Pharmaceuticals: EPS against the estimate, last 4 reportsNRX Pharmaceuticals: EPS against the estimate, last 4 reportsEstimateReported−$0.02−$0.51Nov 25−$0.08$0.18Mar 26−$0.11−$0.04May 26−$0.13−$0.24Aug 26
Latest (Aug 26): Estimate −$0.13, Reported −$0.24.

NRX Pharmaceuticals' latest quarter

NRX Pharmaceuticals, Q2 2026: revenue $1.1M, operating margin -590.8%, net loss $16.5M, operating cash flow −$8.9M. The chart follows the revenue to costs, profit and cash.

Questions

When does NRXP report earnings?

NRX Pharmaceuticals is expected to report on Nov 12, 2026 (estimated).

What are analysts expecting from NRX Pharmaceuticals?

EPS of −$0.15 and revenue of $1.3M for the quarter.

Does NRX Pharmaceuticals usually beat earnings?

It beat the consensus EPS estimate in 50% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.